Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents

Despite advances in the development of clinical agents for treating Mantle Cell Lymphoma (MCL), treatment of MCL remains a challenge due to complexity and frequent relapse associated with MCL. The incorporation of conventional and novel diagnostic approaches such as genomic sequencing have helped im...

Descripción completa

Detalles Bibliográficos
Autores principales: Inamdar, Arati A., Goy, Andre, Ayoub, Nehad M., Attia, Christen, Oton, Lucia, Taruvai, Varun, Costales, Mark, Lin, Yu-Ting, Pecora, Andrew, Suh, Stephen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217048/
https://www.ncbi.nlm.nih.gov/pubmed/27119356
http://dx.doi.org/10.18632/oncotarget.8961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217048/
https://www.ncbi.nlm.nih.gov/pubmed/27119356
http://dx.doi.org/10.18632/oncotarget.8961

Ejemplares similares